Skip to main content

Table 1 Summary of dropout reasons by treatment at the final follow-up

From: Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study

Status Magnesium, n (%) Placebo, n (%) Total, n (%)
Baseline ASS assessment completed 248 (49.4) 254 (50.6) 502
Completed follow-up 185 (74.6) 217 (85.4) 402 (80.1)
Overall dropout 63 (25.4) 37 (14.6) 100 (19.9)
 Case 1: Due to good prognosis 10 (15.9) 5 (13.5) 15 (15.0)
 Case 2: Due to poor prognosis 1 (1.6) 3 (8.1) 4 (4.0)
 Case 3: Due to unknown or unclear reasons 11 (17.4) 9 (24.3) 20 (20.0)
 Case 4: Unlikely to be related to the patient’s concurrent health status 41 (65.1) 20 (54.1) 61 (61.0)
  1. ASS Asthma Severity Score